PENGARUH KARAKTERISTIK PASIEN TERHADAP POLA PERESEPAN OBAT ANTIHIPERTENSI DI PUSKESMAS DEKET KABUPATEN LAMONGAN

Muhammad Syariful Imam; Zaenal Fanani

doi:10.59003/nhj.v5i8.1916

Authors

Muhammad Syariful Imam Universitas Muhammadiyah Kudus
Zaenal Fanani Universitas Muhammadiyah Kudus

DOI:

https://doi.org/10.59003/nhj.v5i8.1916

Keywords:

hypertension, patient characteristics, prescribing pattern

Abstract

Hypertension is a non-communicable disease with a continuously increasing prevalence and contributes significantly to the incidence of cardiovascular disease. In service practice, antihypertensive drug prescribing patterns still show variations influenced by age, gender, and comorbidities. This study aims to analyze the influence of patient characteristics on antihypertensive drug prescribing patterns at the Deket Community Health Center in Lamongan Regency. This study used a retrospective and cross-sectional design. Research data were obtained from prescriptions and medical records of hypertensive patients for the period November 2025. The study population included all prescriptions containing antihypertensive drugs, with a sample of 85 prescriptions taken using a simple random sampling technique. Independent variables included age, gender, and comorbidities, while the dependent variable was the antihypertensive drug prescribing pattern. Data analysis was performed descriptively and analytically using appropriate statistical tests. The results of the study at the Deket Community Health Center, Lamongan Regency, the most were women at 76% (65 patients), the most aged ≥60 at 54.12% (46 patients), with comorbidities of diabetes mellitus at 55.29% (47 respondents). The description of the accuracy of antihypertensive prescription patterns at the Deket Community Health Center, Lamongan Regency based on the correct indication was 100%, the correct patient was 92.94% of cases, the correct drug reached 95.29%, the correct dose was 65 prescriptions (76.47%) and the correct method of use was 70.59%. There is a significant relationship between gender and prescribing patterns with a significance value of 0.013 <0.05 with an odds ratio of 0.252, there is no significant relationship between age and prescribing patterns with a significance value of 0.235>0.05 and an odds ratio of 1.682 and there is a significant relationship between comorbidities and prescribing patterns with a significance value of 0.019 <0.05 and a fairly large odds ratio value between the two characteristics, namely 3.000.

Downloads

Download data is not yet available.

References

Abegaz, T. M., Tefera, Y. G., & Abebe, T. B. (2017). Antihypertensive drug prescription patterns and their impact on outcome of blood pressure in Ethiopia: A hospital-based cross-sectional study. Integrated Pharmacy Research and Practice, 6, 29–35. https://doi.org/10.2147/IPRP.S124047

Adistia, E. A., & Dini, I. R. E. (2022). Hubungan antara rasionalitas penggunaan antihipertensi terhadap keberhasilan terapi pasien hipertensi di RSND Semarang. Generics: Journal of Research in Pharmacy, 2(1), 24–36.

American Diabetes Association. (2022). Standards of medical care in diabetes—2022. Diabetes Care, 45(Suppl. 1), S1–S264. https://doi.org/10.2337/dc22-Sint

Bager, J. E. (2023). Hypertension: Sex-related differences in drug treatment. Journal of Human Hypertension, 37, 123–134.

Bally, M., Dendukuri, N., Rich, B., et al. (2022). Risk of acute myocardial infarction with NSAIDs in real world use. BMJ, 357, j1909. https://doi.org/10.1136/bmj.j1909

Berrett, T. B., Wang, Y., Barber, R. F., & Samworth, R. J. (2021). USP: An independence test that improves on Pearson’s chi-square test. Proceedings of the Royal Society A, 477(2256), 20210549. https://doi.org/10.1098/rspa.2021.0549

Burnier, M., & Egan, B. M. (2020). Drug adherence in hypertension. Circulation Research, 124(7), 1124–1140.

Carey, R. M., & Whelton, P. K. (2021). Prevention, detection, evaluation, and management of hypertension in adults. Journal of the American College of Cardiology, 77(19), 2482–2495. https://doi.org/10.1016/j.jacc.2021.03.297

Dal Canto, E., et al. (2025). Sex differences in the prescription of antihypertensive medications in primary care patients: An observational study. Primary Care Journal.

Davies, M. J., et al. (2022). Management of hyperglycemia in type 2 diabetes. Diabetes Care, 45(Suppl. 1), S125–S143.

Dipiro, J. T., et al. (2020). Pharmacotherapy: A pathophysiologic approach. McGraw-Hill.

European Society of Cardiology. (2023). ESC guidelines for the management of arterial hypertension.

Fadhilah, S., Rusliani, D. M., Nuryati, A., & Suryantara, B. (2025). Deteksi dini faktor risiko penyakit tidak menular pada remaja karang taruna: Skrining dan upaya pencegahan. Room of Civil Society Development, 4(1), 222–233.

Fajarsari, Y. (2021). Hubungan tingkat pengetahuan tentang hipertensi dengan perilaku pencegahan terjadinya hipertensi pada jemaah haji di wilayah kerja Puskesmas Kotagede I Yogyakarta (Tesis doktoral, Poltekkes Kemenkes Yogyakarta). http://eprints.poltekkesjogja.ac.id/5542/

Gailea, N. (2023). Analisis faktor-faktor kejadian hipertensi pada remaja di Kelurahan Ragunan Jakarta Selatan tahun 2023 (Tesis doktoral, Universitas Nasional). http://repository.unas.ac.id/id/eprint/6676

Harrison, D. G., Coffman, T. M., & Wilcox, C. S. (2021). Pathophysiology of hypertension. Circulation Research, 128(7), 847–863. https://doi.org/10.1161/CIRCRESAHA.121.318082

James, P. A., Oparil, S., Carter, B. L., et al. (2019). Evidence-based guideline for the management of high blood pressure in adults. JAMA, 322(20), 2019–2035.

Jarari, N., Rao, N., Peela, J. R., et al. (2016). A review on prescribing patterns of antihypertensive drugs. Clinical Hypertension, 22(1), 7. https://doi.org/10.1186/s40885-016-0042-0

Jiao, T., Platt, R. W., Douros, A., & Filion, K. B. (2022). Prescription patterns for the use of antihypertensive drugs for primary prevention among patients with hypertension in the United Kingdom. American Journal of Hypertension, 35(1), 42–53. https://doi.org/10.1093/ajh/hpab137

Kementerian Kesehatan Republik Indonesia. (2018). Laporan nasional Riskesdas 2018. Badan Penelitian dan Pengembangan Kesehatan.

Kementerian Kesehatan Republik Indonesia. (2020). Pedoman teknis penatalaksanaan hipertensi.

Kementerian Kesehatan Republik Indonesia. (2023). Profil kesehatan Indonesia tahun 2022.

Kidney Disease: Improving Global Outcomes. (2021). KDIGO 2021 clinical practice guideline for the management of chronic kidney disease. Kidney International Supplements, 11(1), 1–150.

Krousel-Wood, M., Craig, L. S., Peacock, E., et al. (2021). Medication adherence: Expanding the conceptual framework. American Journal of Hypertension, 34(9), 895–909.

Lin, P. D., Rifas-Shiman, S., Merriman, J., et al. (2024). Trends of antihypertensive prescription among US adults from 2010 to 2019 and changes following treatment guidelines: Analysis of multicenter electronic health records. Journal of the American Heart Association, 13(9), e032197. https://doi.org/10.1161/JAHA.123.032197

Mancia, G., et al. (2023). Hypertension management in older adults. Journal of Hypertension, 41(2), 215–230.

Nieuwlaat, R., et al. (2020). Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews.

Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. (2020). Pedoman tatalaksana hipertensi. PERKI.

Perkumpulan Endokrinologi Indonesia. (2021). Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia.

Pratiwi, N. L., et al. (2021). Evaluasi ketepatan dosis obat antihipertensi pada pasien rawat jalan. Jurnal Farmasi Klinik Indonesia, 10(2), 85–94.

Rouette, J., McDonald, E. G., Schuster, T., Brophy, J. M., & Azoulay, L. (2022). Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: A population-based cohort study. BMJ Open, 12(6), e057510. https://doi.org/10.1136/bmjopen-2021-057510

Unger, T., et al. (2020). 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension, 75(6), 1334–1357.

Whelton, P. K., et al. (2018). 2017 ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension, 71(6), e13–e115.

Williams, B., Mancia, G., Spiering, W., et al. (2020). 2020 ESC guidelines for the management of arterial hypertension. European Heart Journal, 41(1), 111–188. https://doi.org/10.1093/eurheartj/ehz486

World Health Organization. (2019). WHO guide to good prescribing: A practical manual. WHO.